MED — Medartis Holding AG Share Price
0.000.00%
Last trade - 00:00- CH₣1.10bn
- CH₣1.12bn
- CH₣212.01m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 90.92 | ||
| PEG Ratio (f) | 1.54 | ||
| EPS Growth (f) | 143.87% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.31 | ||
| Price to Tang. Book | 5.77 | ||
| Price to Free Cashflow | 937.09 | ||
| Price to Sales | 5.18 | ||
| EV to EBITDA | 36.63 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3% | ||
| Return on Equity | 0.25% | ||
| Operating Margin | 4.29% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CH₣m | 130.14 | 127.65 | 159.88 | 182.82 | 212.01 | 246.55 | 286.84 | 11.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -53.76 | -91.65 | +3939.32 | n/a | n/a | +183.46 | +108.82 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. It has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.
Directors
- H. C. Straumann CHM (57)
- Christoph Broennimann CEO (54)
- Dominique Leutwyler DCE (50)
- Dominik Ellenrieder VCH (62)
- Lisa Thompson CEX (64)
- Anthony Durieux-Menage CHO (46)
- Manuel Schaer CTO (51)
- Mareike Loch VPR (51)
- Axel Maltzen MGB (51)
- Juerg Greuter DRC (64)
- Daniel Herren DRC (58)
- Roland Hess DRC (69)
- Willi Miesch DRC (56)
- Damien Tappy DRC (51)
- Marco Gadola NED (58)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 3rd, 1997
- Public Since
- March 23rd, 2018
- No. of Shareholders
- 2,120
- No. of Employees
- 829
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- SIX Swiss Exchange
- Shares in Issue
- 13,558,850
- Address
- Hochbergerstrasse 60E, BASEL, 4057
- Web
- https://www.medartis.com/
- Phone
- +41 616333434
- Contact
- Fabian Hildbrand
- Auditors
- Ernst & Young AG
Upcoming Events for MED
Medartis Holding AG Annual Shareholders Meeting
Medartis Holding AG Investor Meeting
Medartis Holding AG at Pan European Small and Mid-Cap Conference
Half Year 2024 Medartis Holding AG Earnings Release
Similar to MED
Alcon AG
SIX Swiss Exchange
COLTENE Holding AG
SIX Swiss Exchange
IVF Hartmann Holding AG
SIX Swiss Exchange
Medacta SA
SIX Swiss Exchange
medmix AG
SIX Swiss Exchange
FAQ
What is the Medartis Holding AG share price?
As of Today at 19:14 UTC, shares in Medartis Holding AG are trading at CH₣81.00. This share price information is delayed by 15 minutes.
How has the Medartis Holding AG share price performed this year?
Shares in Medartis Holding AG last closed at CH₣81.00 and the price had moved by +18.25% over the past 365 days. In terms of relative price strength the Medartis Holding AG share price has outperformed the FTSE Global All Cap Index by +9.07% over the past year.
What are the analyst and broker recommendations for Medartis Holding AG?
The overall consensus recommendation for Medartis Holding AG is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Medartis Holding AG dividend yield?
Medartis Holding AG does not currently pay a dividend.
Does Medartis Holding AG pay a dividend?
Medartis Holding AG does not currently pay a dividend.
When does Medartis Holding AG next pay dividends?
Medartis Holding AG does not currently pay a dividend.
How do I buy Medartis Holding AG shares?
To buy shares in Medartis Holding AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medartis Holding AG?
As of the previous close price of CH₣81.00, shares in Medartis Holding AG had a market capitalisation of CH₣1.10bn.
Where are Medartis Holding AG shares listed?
Here are the trading details for Medartis Holding AG:
- Country of listing: Switzerland
- Exchange: SWX
- Ticker Symbol: MED
What kind of share is Medartis Holding AG?
Based on an overall assessment of its quality, value and momentum Medartis Holding AG is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medartis Holding AG share price forecast for 2024?
The analyst consensus target price for shares in Medartis Holding AG is CH₣103.50. That is 27.78% above the last closing price of CH₣81.00.
Analysts covering Medartis Holding AG currently have a consensus Earnings Per Share (EPS) forecast of CH₣0.68 for the next financial year.
What is the trend in the Medartis Holding AG share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medartis Holding AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -10.56%.
As of the last closing price of CH₣81.00, shares in Medartis Holding AG were trading +3.71% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medartis Holding AG PE Ratio?
The Medartis Holding AG PE ratio based on its reported earnings over the past 12 months is 90.92. The shares last closed at CH₣81.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medartis Holding AG?
Medartis Holding AG's management team is headed by:
- H. C. Straumann - CHM
- Christoph Broennimann - CEO
- Dominique Leutwyler - DCE
- Dominik Ellenrieder - VCH
- Lisa Thompson - CEX
- Anthony Durieux-Menage - CHO
- Manuel Schaer - CTO
- Mareike Loch - VPR
- Axel Maltzen - MGB
- Juerg Greuter - DRC
- Daniel Herren - DRC
- Roland Hess - DRC
- Willi Miesch - DRC
- Damien Tappy - DRC
- Marco Gadola - NED